UK boasts ‘biggest bioscience cluster in Europe’

The UK is the “biggest biosciences cluster in Europe” a report by the BioIndustry Association has said.

October 15, 2013

The State of the Nation, co-written by the association with analysts at Ernst and Young, presents a “new positive mood” in UK bioscience in the wake of the global economic crisis.

According to the report, the UK has the largest pipeline of products of any biotech cluster outside the US - behind just New England, the San Francisco Bay area and San Diego - and is the best place for raising innovation capital in Europe.

It also boasts that the UK has six of the world’s “top 50 universities for clinical, pre-clinical and health research”, apparently referring to the Times Higher Education World University Rankings 2012.

Released at the association’s UK Bioscience Forum in London on 10 October, the report also says that government-backed models, such as the biomedical catalyst and regional growth fund, have played “a big part in catalysing investment in the UK” while venture capital has been constrained.

However writing in the introduction, Ian Oliver, executive director at Ernst and Young, adds that there are “few, if any, signs” that UK investors are ready to support biotech businesses floating on the stock market.

His sentiments were backed up by Andrew Jack, pharmaceuticals correspondent for the Financial Times, who speaking at the event said it was important “to caution against hype, and over optimism, also against complacency and even, dare I say it, increasingly perhaps, nationalism”.

“I think we’ve got to look global much more than country by country,” he added.

The ability to move beyond early stage academic research and start-ups to large enough bodies of experienced executives capable of taking companies to the next stage was still an issue, as was the gap in funding to do so, he said.  

He also highlighted how big pharmaceutical companies had restructured and narrowed their focus in the UK, and commented that other countries had similar government incentives to invest.

“Internationally, if I were an entrepreneur or funder with a global choice I’m still not entirely convinced the UK would be my first port of call, if there weren’t other historical reasons for being here,” he said.

Meanwhile on the same day the University of Cambridge launched a £50 million investment business to support the development of university spin-outs and other early-stage technology companies around the city.

Cambridge Innovation Capital, backed by funding from Invesco Perpetual and Lansdowne Partners, as well as the university’s endowment fund, ARM Holdings and IP Group, is intended to help companies “bridge the critical middle stage of commercial development”, said the university in a statement.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Featured Jobs

Most Commented

Worried man wiping forehead
Two academics explain how to beat some of the typical anxieties associated with a doctoral degree
A group of flamingos and a Marabou stork

A right-wing philosopher in Texas tells John Gill how a minority of students can shut down debates and intimidate lecturers – and why he backs Trump

A face made of numbers looks over a university campus

From personalising tuition to performance management, the use of data is increasingly driving how institutions operate

students use laptops

Researchers say students who use computers score half a grade lower than those who write notes

As the country succeeds in attracting even more students from overseas, a mixture of demographics, ‘soft power’ concerns and local politics help explain its policy